145 related articles for article (PubMed ID: 21371524)
1. Usefulness of serum S100B as a marker for the acute phase of aquaporin-4 autoimmune syndrome.
Fujii C; Tokuda T; Ishigami N; Mizuno T; Nakagawa M
Neurosci Lett; 2011 Apr; 494(1):86-8. PubMed ID: 21371524
[TBL] [Abstract][Full Text] [Related]
2. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
[TBL] [Abstract][Full Text] [Related]
3. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
Jarius S; Aboul-Enein F; Waters P; Kuenz B; Hauser A; Berger T; Lang W; Reindl M; Vincent A; Kristoferitsch W
Brain; 2008 Nov; 131(Pt 11):3072-80. PubMed ID: 18945724
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of IgG-NMO autoantibodies on S100Beta protein and disability in relapsing neuromyelitis optica.
Robinson-Agramonte MA; Gonçalves CA; Portela LV; Saiz-Hinarejos A; Oses JP; Motta LS; Muller AP; Marquez Gonzalez ME; Souza DO
Neuroimmunomodulation; 2010; 17(3):177-9. PubMed ID: 20134196
[TBL] [Abstract][Full Text] [Related]
5. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
[TBL] [Abstract][Full Text] [Related]
6. Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.
Kim W; Lee JE; Li XF; Kim SH; Han BG; Lee BI; Kim JK; Choi K; Kim HJ
Mult Scler; 2012 May; 18(5):578-86. PubMed ID: 21965418
[TBL] [Abstract][Full Text] [Related]
7. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
Misu T; Fujihara K; Itoyama Y
Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
[TBL] [Abstract][Full Text] [Related]
8. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
[TBL] [Abstract][Full Text] [Related]
9. Serum GFAP levels in optic neuropathies.
Storoni M; Verbeek MM; Illes Z; Marignier R; Teunissen CE; Grabowska M; Confavreux C; Plant GT; Petzold A
J Neurol Sci; 2012 Jun; 317(1-2):117-22. PubMed ID: 22410258
[TBL] [Abstract][Full Text] [Related]
10. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
Jarius S; Jacobi C; de Seze J; Zephir H; Paul F; Franciotta D; Rommer P; Mader S; Kleiter I; Reindl M; Akman-Demir G; Seifert-Held T; Kristoferitsch W; Melms A; Wandinger KP; Wildemann B
Mult Scler; 2011 Sep; 17(9):1067-73. PubMed ID: 21543553
[TBL] [Abstract][Full Text] [Related]
11. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
[TBL] [Abstract][Full Text] [Related]
12. Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.
Jarius S; Franciotta D; Paul F; Bergamaschi R; Rommer PS; Ruprecht K; Ringelstein M; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2012 Sep; 320(1-2):32-7. PubMed ID: 22705047
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
[TBL] [Abstract][Full Text] [Related]
15. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
[TBL] [Abstract][Full Text] [Related]
16. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
17. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker.
Misu T; Takano R; Fujihara K; Takahashi T; Sato S; Itoyama Y
J Neurol Neurosurg Psychiatry; 2009 May; 80(5):575-7. PubMed ID: 19372295
[TBL] [Abstract][Full Text] [Related]
18. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.
Jarius S; Probst C; Borowski K; Franciotta D; Wildemann B; Stoecker W; Wandinger KP
J Neurol Sci; 2010 Apr; 291(1-2):52-6. PubMed ID: 20117794
[TBL] [Abstract][Full Text] [Related]
19. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
[TBL] [Abstract][Full Text] [Related]
20. Anti-aquaporin-4 antibody-positive optic neuritis.
Takagi M; Tanaka K; Suzuki T; Miki A; Nishizawa M; Abe H
Acta Ophthalmol; 2009 Aug; 87(5):562-6. PubMed ID: 19021599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
